$6.51
-0.13-1.96%
가까이에: Sep 29, 5:00 PM EST
$6.52
0.010.15%
시간외: 4:38 PM EST
Benzinga
Benzinga
Benzinga
수요일, 9월 30
Starling Oncology Inc
STLNNASDAQ
Starling Oncology Earnings & Forecasts
Starling Oncology (STLN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Starling Oncology Guidance
Starling Oncology (STLN)는 8월 6, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $650M - $670M 범위로 예상했습니다.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.06 | $-0.08 | $-0.09 | $-0.12 |
| Actual | $-0.08 | $-0.02 | $-0.06 | $-0.14 |
| Surprise | -33.3% | +75.0% | +33.3% | -16.7% |
| Revenue | ||||
| Estimate | $156.9M | $142.6M | $140.3M | $122.5M |
| Actual | $161.3M | $147.4M | $142.0M | $136.6M |
| Surprise | +2.79% | +3.38% | +1.20% | +11.5% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.05 | $-0.02 |
| Revenue | ||
| Consensus | $168.6M | $187.8M |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved